ALT Blood Test
Understanding Alanine Aminotransferase from liver-cell injury and blood sample collection to analyser measurement, Biomedical Scientist review and clinical decision-making.
Quick Facts
Alanine Aminotransferase (ALT) is a Clinical Chemistry enzyme test used mainly to support assessment of hepatocellular injury. It is interpreted with the patient’s clinical history, medication history, sample quality, local reference interval and wider liver-test pattern.
Clinical Significance
ALT is an intracellular aminotransferase enzyme. In routine clinical practice it is requested as part of a liver profile or wider biochemical screen to help identify, monitor or investigate patterns of liver-cell injury. ALT activity in blood usually remains low when hepatocyte membranes are intact. When hepatocytes are injured, enzyme leakage into the circulation can increase measured ALT activity.
ALT is often described as more liver-associated than AST, although it is not completely liver-specific. Small amounts are found in other tissues, and clinical interpretation must take account of symptoms, medication, alcohol intake, metabolic risk factors, viral hepatitis risk, muscle injury, pregnancy context and other biochemical results.
ALT contributes to recognising hepatocellular patterns, especially when compared with AST, ALP, GGT and bilirubin.
Serial ALT results may support monitoring of chronic liver disease, medication effects, metabolic-associated steatotic liver disease and recovery after acute injury.
What is ALT?
ALT participates in amino acid metabolism by catalysing transfer of an amino group between alanine and 2-oxoglutarate. In liver-cell injury, intracellular ALT can leak into the blood and become measurable in serum or plasma.
ALT in context
ALT is clinically useful because it links biochemistry, hepatocyte integrity and laboratory measurement.
Learning point
ALT is interpreted with the full liver-test pattern and local clinical pathway.
Principle of the Assay
Many modern Clinical Chemistry ALT methods use an IFCC-type enzymatic approach. ALT catalyses a transamination reaction, and a coupled LDH reaction allows the analyser to monitor NADH oxidation by measuring the decrease in absorbance at 340 nm.
ALT transfers an amino group from alanine to 2-oxoglutarate, forming pyruvate and glutamate under assay conditions.
Pyruvate is converted to lactate by LDH while NADH is oxidised to NAD+. NADH absorbs at 340 nm, so absorbance falls as the reaction proceeds.
The analyser measures the rate of absorbance decrease and converts this rate into ALT activity, typically reported in U/L.
Laboratory Workflow
An ALT result is not just a number. It travels through pre-analytical, analytical and post-analytical stages before it reaches a clinical decision.
Patient attends GP, clinic, ward or emergency setting.
Blood collected into a locally validated tube.
Specimen transported according to local policy.
Request, identity and sample suitability checked.
Serum or plasma separated for analysis.
ALT measured on validated chemistry analyser.
QC reviewed before patient results are released.
Flags, indices, trends and plausibility reviewed.
Result released according to governance rules.
Clinician interprets result with patient context.
Specimen Requirements
ALT is commonly measured in serum or plasma on automated Clinical Chemistry analysers. Accepted tube types and stability must follow the current method sheet and local laboratory SOP.
Pre-analytical and Analytical Limitations
Limitations occur before, during and after analysis. A robust ALT guide must explain these clearly because many “abnormal results” first require assessment of specimen integrity and analytical validity.
Green
- Correct patient and sample identification
- Validated tube type
- Appropriate separation and transport
- QC acceptable before reporting
Amber
- Minor delay or borderline sample quality
- Unexpected result requiring trend review
- Need to compare with other liver tests
- Possible medication or exercise contribution
Red
- Severe haemolysis or analyser interference flag
- Incorrect tube or unlabelled sample
- QC failure or calibration concern
- Result unsafe to release without review
Quality Assurance
Quality assurance protects patients by ensuring that the ALT result is analytically valid before it is used clinically.
Result Interpretation
ALT interpretation depends on the local reference interval and clinical context. A result should be viewed alongside AST, ALP, GGT, bilirubin, albumin, total protein, coagulation where appropriate and the patient’s history.
Within local reference interval
A result within the laboratory interval may be reassuring, but it does not exclude all liver disease. Clinical context remains important.
Mild ALT elevation
Mild elevation may be seen with metabolic-associated steatotic liver disease, medication effects, alcohol-related disease, viral hepatitis, recent strenuous exercise or other clinical contexts. Repeating the test or adding further investigations depends on local pathways.
Marked ALT elevation
Marked elevation may suggest significant hepatocellular injury and requires clinical correlation. Urgency depends on symptoms, bilirubin, coagulation, renal function, medication/toxin history and local escalation criteria.
ALT compared with AST
ALT and AST patterns can support interpretation, but ratios are not diagnostic in isolation. Muscle injury, alcohol-related disease, advanced liver disease and acute hepatocellular injury can alter the pattern.
Biomedical Scientist Insight
The analyser can generate flags, indices and reaction data. Biomedical Scientists review these alongside QC and local rules to decide whether the result is technically valid.
Incorrect patient details, wrong tube, insufficient sample, severe haemolysis, leakage or compromised transport can make a result unsafe to report.
ALT results influence clinical decisions. QC failure may indicate analytical drift or imprecision, so patient results should not be released until the issue is resolved.
A high ALT may be clinically expected, new, worsening, urgent or inconsistent with the wider picture. Interpretation depends on trends and the full biochemical pattern.
Clinical Case
An adult patient has fatigue and non-specific abdominal discomfort. ALT is raised with mild GGT elevation. Bilirubin and albumin are within the local reference interval.
Sample quality, haemolysis/icterus/lipaemia indices, analyser flags, QC status, previous results and the wider liver-test pattern.
Reveal learning points
ALT elevation should be interpreted with history and other results. The Biomedical Scientist’s role is to ensure the analytical result is valid and appropriately authorised; the clinician decides the diagnostic and management pathway.
Frequently Asked Questions
What does ALT measure?
ALT testing measures enzyme activity in serum or plasma. Increased activity can occur when hepatocytes release intracellular enzyme into the blood.
Does high ALT always mean liver disease?
No. ALT is associated with hepatocellular injury, but it is not a diagnosis by itself. Medication, alcohol, metabolic risk factors, viral hepatitis, muscle injury and other clinical contexts may need consideration.
Can exercise affect ALT?
Strenuous exercise may affect some liver and muscle-related enzymes. Interpretation should include history and other test results, especially AST and creatine kinase if muscle injury is suspected.
How is ALT measured in the laboratory?
Many methods use an enzymatic reaction coupled to NADH oxidation. The analyser monitors a decrease in absorbance at 340 nm and calculates ALT activity from the reaction rate.
Why do reference intervals differ between laboratories?
Reference intervals depend on method, analyser, population, verification process and local governance. Always use the interval supplied with the patient result.
Revision Notes
ALT one-page summary
PDF revision sheet to be generated from this master guide after scientific review.
Interactive Quiz
Use these questions to check understanding. Future versions can support scoring and certificate generation.
Reveal feedback
Correct answer: assessment of hepatocellular injury pattern. ALT is interpreted with other liver tests and clinical context.
Reveal feedback
Correct answer: NADH is oxidised to NAD+. NADH absorbs at 340 nm, so its consumption causes absorbance to decrease.
Reveal feedback
Correct answer: QC and analyser flags should be acceptable. Analytical quality is essential before result release.
Reveal feedback
Correct answer: all ALT patterns. Even a normal ALT may need context if symptoms or risk factors are present.
Reveal feedback
Correct answer: Biomedical Scientists or authorised laboratory staff review results according to local governance.
References and Source Framework
This guide is written as original educational content using a source hierarchy: current manufacturer method sheet, local laboratory information, core textbooks, IFCC/CLSI/ISO principles and professional guidance.